Electromed, Inc.
ELMDElectromed, Inc. (ELMD) is a medical device company focused on developing and commercializing airway clearance solutions. Its flagship product, the AIRWAY RESCUE System, utilizes SmartVest technology to aid patients with conditions such as bronchiectasis, COPD, and cystic fibrosis by helping to loosen and remove mucus from the lungs. The company emphasizes minimally invasive therapies aimed at improving respiratory health and reducing the need for more aggressive treatments.
Company News
Upgrades Northcoast Research upgraded the previous rating for Ecolab Inc (NYSE:ECL) from Neutral to Buy. Ecolab earned $1.10 in the second quarter, compared to $1.22 in the year-ago quarter. The stock has a 52-week-high of $237.38 and a 52-week-low of $143.82. At the end of the last trading period, Ecolab closed at $161.64. According to Northc...
Electromed, Inc. (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Electromed, Inc. (ELMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Electromed, Inc. (ELMD) delivered earnings and revenue surprises of -16.67% and 11.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Electromed, Inc. (ELMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
